Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1975-1986

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walter, M.
Right arrow Articles by Assmann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walter, M.
Right arrow Articles by Assmann, G.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1975-1986.)
© 1995 American Heart Association, Inc.


Articles

HDL3 Stimulates Multiple Signaling Pathways in Human Skin Fibroblasts

Michael Walter; Holger Reinecke; Jerzy-Roch Nofer; Udo Seedorf; Gerd Assmann

From the Institut für Arterioskleroseforschung und Institut für Klinische Chemie und Laboratoriumsmedizin, Zentrallaboratorium, Westfälische Wilhelms-Universität, Münster, Germany.

Correspondence to Dr Michael Walter, Institut für Arterioskleroseforschung an der Westfälischen Wilhelms-Universität Münster, Domagkstr 3, 48149 Münster, Germany.

Abstract The influence of HDL3 on phospholipid breakdown was examined in human skin fibroblasts. HDL3 elicited phosphatidylcholine (PC) and phosphatidylinositol (PI) turnover and activated multiple phospholipases. In [14C]lyso-PC–labeled or [14C]choline (Cho)-labeled cells, a biphasic activation of PC-specific phospholipase D (PLD) with peak maxima 30 to 60 seconds and 5 to 7 minutes after stimulation with 20 µg/mL HDL3 was shown by (1) a 1.5- to 3-fold increase in [14C]phosphatidic acid (PA), (2) a 1.6-fold increase in Cho release, and (3) transphosphatidylation of PC to phosphatidylbutanol in the presence of 0.3% butanol. Activation of PC-specific PLD was paralleled by an activation of PC-specific phospholipase C (PLC). A significant increase in [14C]diacylglycerol (DG) was seen from 2 minutes after stimulation onward and remained for at least 2 hours. By means of butanol, the PA-phosphohydrolase (PPH) inhibitor propranolol, and the PC-PLC inhibitor D609, we demonstrated that the initial PC-derived DG formation occurred primarily by a coupled PLD/PPH pathway and that a major part of the sustained DG formation was derived directly from PC by PC-PLC. By downregulating protein kinase C (PKC) we demonstrated that PKC activates PC-PLC and desensitizes PC-PLD at longer incubation times. The sustained PC hydrolysis as well as HDL3-mediated PI turnover and PC resynthesis was observed on stimulation with 5 to 75 µg/mL HDL3, whereas the rapid activation of PC-PLD/PPH was detected only on stimulation with HDL3 at concentrations of between 10 and 75 µg/mL. Only the latter response could be mimicked by apolipoprotein A-I and apolipoprotein A-II proteoliposomes, and only this response was inducible by cholesterol loading. The HDL3-mediated second-messenger responses were inhibited by modification of HDL3 by tetranitromethane and could not be mimicked by protein-free liposomes. These data suggest that HDL3-induced cell signaling in human skin fibroblasts is mediated by specific protein-receptor interaction and that more than one agonist activity may be involved.


Key Words: high-density lipoprotein • apolipoprotein A-I • apolipoprotein A-II • signal transduction • cholesterol efflux




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Walter
Interrelationships Among HDL Metabolism, Aging, and Atherosclerosis
Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1244 - 1250.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. F. Oram and J. W. Heinecke
ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease
Physiol Rev, October 1, 2005; 85(4): 1343 - 1372.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-R. Nofer, R. Feuerborn, B. Levkau, A. Sokoll, U. Seedorf, and G. Assmann
Involvement of Cdc42 Signaling in ApoA-I-induced Cholesterol Efflux
J. Biol. Chem., December 26, 2003; 278(52): 53055 - 53062.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yamauchi, M. Hayashi, S. Abe-Dohmae, and S. Yokoyama
Apolipoprotein A-I Activates Protein Kinase C{alpha} Signaling to Phosphorylate and Stabilize ATP Binding Cassette Transporter A1 for the High Density Lipoprotein Assembly
J. Biol. Chem., November 28, 2003; 278(48): 47890 - 47897.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. von Eckardstein, J.-R. Nofer, and G. Assmann
High Density Lipoproteins and Arteriosclerosis : Role of Cholesterol Efflux and Reverse Cholesterol Transport
Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 13 - 27.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Vinals, J. Martinez-Gonzalez, and L. Badimon
Regulatory Effects of HDL on Smooth Muscle Cell Prostacyclin Release
Arterioscler Thromb Vasc Biol, October 1, 1999; 19(10): 2405 - 2411.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
U. Daum, T. P. Leren, C. Langer, A. Chirazi, P. Cullen, P. H. Pritchard, G. Assmann, and A. von Eckardstein
Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers
J. Lipid Res., March 1, 1999; 40(3): 486 - 494.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
N. H. Fidge
High density lipoprotein receptors, binding proteins, and ligands
J. Lipid Res., February 1, 1999; 40(2): 187 - 201.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-R. Nofer, M. Walter, B. Kehrel, S. Wierwille, M. Tepel, U. Seedorf, and G. Assmann
HDL3-Mediated Inhibition of Thrombin-Induced Platelet Aggregation and Fibrinogen Binding Occurs via Decreased Production of Phosphoinositide-Derived Second Messengers 1,2-Diacylglycerol and Inositol 1,4,5-tris-Phosphate
Arterioscler Thromb Vasc Biol, June 1, 1998; 18(6): 861 - 869.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. von Eckardstein, A. Chirazi, S. Schuler-Lüttmann, M. Walter, J. J. P. Kastelein, J. Geisel, J. T. Real, R. Miccoli, G. Noseda, G. Höbbel, et al.
Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I
J. Lipid Res., May 1, 1998; 39(5): 987 - 998.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Vinals, J. Martinez-Gonzalez, J. J. Badimon, and L. Badimon
HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2)
Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3481 - 3488.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. S. Garver, M. A. Deeg, R. F. Bowen, M. M. Culala, E. L. Bierman, and J. F. Oram
Phosphoproteins Regulated by the Interaction of High-Density Lipoprotein With Human Skin Fibroblasts
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2698 - 2706.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A. Deeg, R. F. Bowen, J. F. Oram, and E. L. Bierman
High Density Lipoproteins Stimulate Mitogen-Activated Protein Kinases in Human Skin Fibroblasts
Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1667 - 1674.
[Abstract] [Full Text]


Home page
CirculationHome page
J.-R. Nofer, M. Tepel, B. Kehrel, S. Wierwille, M. Walter, U. Seedorf, W. Zidek, and G. Assmann
Low-Density Lipoproteins Inhibit the Na+/H+ Antiport in Human Platelets: A Novel Mechanism Enhancing Platelet Activity in Hypercholesterolemia
Circulation, March 18, 1997; 95(6): 1370 - 1377.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J.-R. Nofer, B. Levkau, I. Wolinska, R. Junker, M. Fobker, A. von Eckardstein, U. Seedorf, and G. Assmann
Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids
J. Biol. Chem., September 7, 2001; 276(37): 34480 - 34485.
[Abstract] [Full Text] [PDF]